Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alkermes, Inc.
Alkermes' Corporate Presentation to be Webcast at the Jefferies & Company 3rd Annual Healthcare Conference
July 3rd, 2009
Alkermes, Inc. (NASDAQ: ALKS) announced that its corporate presentation will be webcast live by Jefferies & Company on Wednesday, June 17, 2009, at 2:00 p.m. ET from New York City. The presentation may be accessed under the investor relations tab at www.alkermes.com. The presentation will be archived for 14 days. Alkermes, Inc. is a fully integrated biotechnology company committed to developing innovative medicines to improve patients' lives. Alkermes developed, manufactures and commercializes VIVITROL® for alcohol dependence and manufactures RISPERDAL® CONSTA® for schizophrenia and bipolar disorder. Alkermes' robust pipeline includes extended-release injectable,...
Source: Health Business Week (2009-07-03)
|
